Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v26-EN Version v15-FR
Language English French
Date Updated 2018-01-11 2017-12-05
Drug Identification Number 02241602 02241602
Brand name LIPIDIL SUPRA LIPIDIL SUPRA
Common or Proper name LIPIDIL SUPRA LIPIDIL SUPRA
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients FENOFIBRATE FENOFIBRATE
Strength(s) 160MG 160MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 3x10 3x10
ATC code C10AB C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-09-08 2017-09-08
Estimated end date 2017-12-15
Actual end date 2018-01-10
Shortage status Resolved Actual shortage
Company comments
Health Canada comments